- Home
- TC vs KTTA Comparison
TC vs KTTA Comparison
Compare TC & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TC
- KTTA
- Stock Information
- Founded
- TC 2010
- KTTA 2020
- Country
- TC China
- KTTA United States
- Employees
- TC N/A
- KTTA N/A
- Industry
- TC Business Services
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- TC Consumer Discretionary
- KTTA Health Care
- Exchange
- TC Nasdaq
- KTTA Nasdaq
- Market Cap
- TC 2.4M
- KTTA 2.8M
- IPO Year
- TC 2018
- KTTA 2021
- Fundamental
- Price
- TC $0.76
- KTTA $0.93
- Analyst Decision
- TC
- KTTA
- Analyst Count
- TC 0
- KTTA 0
- Target Price
- TC N/A
- KTTA N/A
- AVG Volume (30 Days)
- TC 544.5K
- KTTA 13.9M
- Earning Date
- TC 06-10-2025
- KTTA 05-15-2025
- Dividend Yield
- TC N/A
- KTTA N/A
- EPS Growth
- TC N/A
- KTTA N/A
- EPS
- TC N/A
- KTTA N/A
- Revenue
- TC $6,737,269.00
- KTTA N/A
- Revenue This Year
- TC N/A
- KTTA N/A
- Revenue Next Year
- TC N/A
- KTTA N/A
- P/E Ratio
- TC N/A
- KTTA N/A
- Revenue Growth
- TC N/A
- KTTA N/A
- 52 Week Low
- TC $0.46
- KTTA $0.79
- 52 Week High
- TC $4.30
- KTTA $7.50
- Technical
- Relative Strength Index (RSI)
- TC 55.96
- KTTA 41.13
- Support Level
- TC $0.74
- KTTA $0.79
- Resistance Level
- TC $0.86
- KTTA $1.00
- Average True Range (ATR)
- TC 0.09
- KTTA 0.11
- MACD
- TC 0.00
- KTTA 0.01
- Stochastic Oscillator
- TC 51.33
- KTTA 41.52
About TC TuanChe Limited
Token Cat Ltd is an omnichannel automotive marketplace in China. The company operates in one segment, providing auto shows, special promotion event services, virtual dealerships, online marketing services, and more. It organizes auto shows to facilitate transactions between consumers and auto dealers, which include auto dealers, automakers, and automotive service providers. It offers services through its online platform and offline events.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).